QuadMedicine, Inc. (KOSDAQ:464490)
8,220.00
+10.00 (0.12%)
At close: Jun 5, 2026
QuadMedicine Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 11,946 | 26,507 | 10,263 | 4,449 |
Short-Term Investments | 12,510 | 1,010 | - | - |
Cash & Short-Term Investments | 24,456 | 27,517 | 10,263 | 4,449 |
Cash Growth | 301.26% | 168.12% | 130.69% | - |
Accounts Receivable | - | 1,803 | 1,100 | 18.41 |
Other Receivables | 423.29 | 393.82 | 3.22 | 0.23 |
Receivables | 1,174 | 2,974 | 1,103 | 18.64 |
Prepaid Expenses | 0.77 | 8.05 | 86.89 | 512.18 |
Other Current Assets | 538.9 | 540.93 | 232.97 | 69.03 |
Total Current Assets | 26,169 | 31,040 | 11,686 | 5,049 |
Property, Plant & Equipment | 19,573 | 19,299 | 19,752 | 19,549 |
Long-Term Investments | - | - | 10 | - |
Other Intangible Assets | 577.51 | 597.95 | 493.21 | 364.21 |
Long-Term Accounts Receivable | -0 | -0 | -0 | -0 |
Other Long-Term Assets | 270.46 | 242.17 | 157.35 | 257.19 |
Total Assets | 46,590 | 51,179 | 32,098 | 25,219 |
Short-Term Debt | 500 | 500 | 500 | - |
Current Portion of Long-Term Debt | 5,900 | 5,900 | 99.6 | - |
Current Portion of Leases | 307.94 | 283.22 | 206.35 | 295.71 |
Other Current Liabilities | 3,418 | 4,138 | 5,524 | 3,616 |
Total Current Liabilities | 10,126 | 10,821 | 6,330 | 3,912 |
Long-Term Debt | 526.1 | 551 | 6,451 | 5,800 |
Long-Term Leases | 311.88 | 249.76 | 106.84 | 327.7 |
Other Long-Term Liabilities | 8,736 | 8,759 | 7,611 | 6,217 |
Total Liabilities | 19,699 | 20,380 | 20,498 | 16,256 |
Common Stock | 5,741 | 5,671 | 4,676 | 4,358 |
Additional Paid-In Capital | 72,840 | 71,338 | 45,483 | 38,472 |
Retained Earnings | -53,227 | -48,619 | -41,688 | -36,720 |
Comprehensive Income & Other | 1,537 | 2,409 | 3,128 | 2,853 |
Shareholders' Equity | 26,891 | 30,799 | 11,600 | 8,963 |
Total Liabilities & Equity | 46,590 | 51,179 | 32,098 | 25,219 |
Total Debt | 7,546 | 7,484 | 7,363 | 6,423 |
Net Cash (Debt) | 16,910 | 20,033 | 2,899 | -1,975 |
Net Cash Growth | - | 590.96% | - | - |
Net Cash Per Share | 1659.31 | 2086.14 | 332.59 | -228.65 |
Filing Date Shares Outstanding | 11.7 | 11.34 | 9.35 | 8.74 |
Total Common Shares Outstanding | 11.7 | 11.34 | 9.35 | 8.74 |
Working Capital | 16,044 | 20,219 | 5,356 | 1,137 |
Book Value Per Share | 2299.33 | 2715.63 | 1240.40 | 1025.97 |
Tangible Book Value | 26,313 | 30,201 | 11,107 | 8,599 |
Tangible Book Value Per Share | 2249.95 | 2662.91 | 1187.66 | 984.28 |
Land | 2,187 | 2,187 | 2,187 | 1,951 |
Buildings | 9,683 | 9,683 | 9,683 | 8,572 |
Machinery | 11,064 | 10,997 | 9,130 | 7,681 |
Construction In Progress | 961.44 | 317.24 | 171.69 | 555.41 |